Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 32.9% | -14.6% | -2.6% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 53.8% | 52.4% | 62.5% | 63.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | -$0 |
| % Margin | 8.1% | 4.1% | 10% | -0.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $2 |
| % Margin | 6.7% | 1.6% | 4.2% | 156.9% |
| EPS | 0.16 | 0.028 | 0.087 | 3.38 |
| % Growth | 463.4% | -67.4% | -97.4% | – |
| EPS Diluted | 0.16 | 0.028 | 0.087 | 3.37 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $2 |
| % Margin | 18.5% | 18.2% | 18.6% | 167.9% |